Tandutinib (MLN518) reverses multidrug resistance by inhibiting the efflux activity of the multidrug resistance protein 7 (ABCC10)

Author:                

Publisher: Spandidos Publications

ISSN: 1021-335X

Source: Oncology Reports, Vol.29, Iss.6, 2013-01, pp. : 2479-2485

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content